TITLE

DOXINATE IN THE TREATMENT OF CONSTIPATION

AUTHOR(S)
Cass, Leo J.; Frederik, Willem S.
PUB. DATE
December 1956
SOURCE
American Journal of Gastroenterology;Dec1956, Vol. 26 Issue 6, p691
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents results of a clinical trial that indicates the use of dioctyl sodium sulfosuccinate in the treatment of certain types of constipation in infants and children, in immobilized patients and in a variety of proctologic conditions. Dependence of the fecal softening action of the drug upon reducing the surface tension at the oil-water interface in the heterogeneous fecal material; Details on the severe types of constipation; Comparison of the effect of dioctyl sodium sulfosuccinate with that of placebo therapy in patients with a long history of chronic functionality constipation.
ACCESSION #
18673993

 

Related Articles

  • Methylnaltrexone: positive results in opiate-induced constipation.  // Reactions Weekly;9/24/2005, Issue 1070, p3 

    Reports on the efficiency of methylnaltrexone therapy in treating constipation distress, bowel movement consistency and difficulty in patients with advanced illness who experienced opiate-induced constipation according to the results of a phase III clinical trial conducted by Progenics...

  • Prucalopride for Severe Constipation.  // Clinical Cardiology Alert;Aug2008 Primary Care Supplement, Vol. 13 Issue 8, p16 

    The article discusses research on the use of prucalopride (PRU) against chronic constipation. It references a study by M. Camilleri et al published in a 2008 issue of the "New England Journal of Medicine." According to a double-blind trial of the drug, thirty one percent of patients taking PRU...

  • Incidence of Ischemic Colitis and Serious Complications of Constipation Among Patients Using Alosetron: Systematic Review of Clinical Trials and Post-Marketing Surveillance Data. Lin Chang; Chey, William D.; Harris, Lucinda; Olden, Kevin; Surawicz, Christina; Schoenfeld, Philip // American Journal of Gastroenterology;May2006, Vol. 101 Issue 5, p1069 

    BACKGROUND: Ischemic colitis and serious complications of constipation have been reported in association with the use of alosetron, which is approved for women with severe diarrhea-predominant IBS who have failed conventional therapies. This systematic review calculated the incidence of these...

  • Effects of moxibustion for constipation treatment: a systematic review of randomized controlled trials. Myeong Soo Lee; Tae-Young Choi; Ji-Eun Park; Ernst, Edzard // Chinese Medicine;2010, Vol. 5, p28 

    Several studies reported that moxibustion was effective in treating constipation. This systematic review assesses the clinical evidence for or against moxibustion for treating constipation. Twelve databases were searched from their inception to March 2010. Only randomized clinical trials (RCTs)...

  • Insulin Glulisine: A Viewpoint by George Dailey. Dailey, George // Drugs;2006, Vol. 66 Issue 6, p870 

    â–´ Lubiprostone (Amitiza) is an oral bicyclic fatty acid that selectively activates type 2 chloride channels in the apical membrane of the gastrointestinal epithelium, resulting in increased fluid secretion.â–´ In two pivotal, randomised, double-blind, multicentre phase III studies in...

  • Insulin Glulisine: A Viewpoint by Mandana Ahmadian and William C. Duckworth. Ahmadian, Mandana; Duckworth, William C // Drugs;2006, Vol. 66 Issue 6, p870 

    â–´ Lubiprostone (Amitiza) is an oral bicyclic fatty acid that selectively activates type 2 chloride channels in the apical membrane of the gastrointestinal epithelium, resulting in increased fluid secretion.â–´ In two pivotal, randomised, double-blind, multicentre phase III studies in...

  • Insulin Glulisine: A Viewpoint by Jürgen Eckel. Eckel, Jürgen // Drugs;2006, Vol. 66 Issue 6, p870 

    â–´ Lubiprostone (Amitiza) is an oral bicyclic fatty acid that selectively activates type 2 chloride channels in the apical membrane of the gastrointestinal epithelium, resulting in increased fluid secretion.â–´ In two pivotal, randomised, double-blind, multicentre phase III studies in...

  • Lubiprostone. McKeage, Kate; Plosker, Greg L.; Siddiqui, M. Asif A. // Drugs;2006, Vol. 66 Issue 6, p873 

    â–´ Lubiprostone (Amitiza) is an oral bicyclic fatty acid that selectively activates type 2 chloride channels in the apical membrane of the gastrointestinal epithelium, resulting in increased fluid secretion.â–´ In two pivotal, randomised, double-blind, multicentre phase III studies in...

  • Polyethylene Glycol for Chronic Constipation. Elliott, William T. // Neurology Alert;Sep2007 Supplement, Vol. 26, p2 

    The article reports on a study from Alabama which found that the long-term use of polyethylene glycol (PEG) is safe and effective for chronic constipation. In the study, more than 300 patients were randomized to receive polyethylene glycol 3350 in a single 17 grams dose per day or placebo for 6...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics